Company Filing History:
Years Active: 2020
Title: Augustinus A M S Van Dongen: Innovator in Cell-Targeting Conjugates
Introduction
Augustinus A M S Van Dongen is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cell-targeting conjugates. With a total of 2 patents, his work focuses on innovative methods that enhance the efficacy of therapeutic compounds.
Latest Patents
Van Dongen's latest patents include a method for preparing cell-targeting conjugates and a method for removing weakly bound functional moieties from these conjugates. The first patent outlines a method that involves coupling at least one functional moiety, such as a therapeutic compound, diagnostic compound, or chelating agent, to a targeting moiety. This method aims to create effective cell-targeting conjugates that can be utilized in pharmaceutical compositions. The second patent describes a method for preparing stable cell-targeting conjugates, which ensures that the conjugates remain effective and stable for medicinal use.
Career Highlights
Augustinus A M S Van Dongen is associated with Linxis B.V., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing the understanding and application of cell-targeting technologies.
Collaborations
He has collaborated with notable colleagues such as Hendrik Jan Houthoff and Dennis Christian Johannes Waalboer, contributing to the development of groundbreaking technologies in their field.
Conclusion
Augustinus A M S Van Dongen is a prominent figure in the realm of pharmaceutical innovations, particularly in the area of cell-targeting conjugates. His patents reflect a commitment to enhancing therapeutic efficacy through innovative methods.